Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
| $43.1M | 0.01% |
488,358
+777
| +0.2% | +$67.6K |
|
1002
TriNet
TNET
$3.14B
| $43M | 0.01% |
451,541
+11,418
| +3% | +$1.14M |
|
1003
Antero Resources
AR
$10.6B
| $43M | 0.01% |
2,456,224
-84,800
| -3% | -$1.61M |
|
1004
ONE Gas
OGS
$4.97B
| $43M | 0.01% |
553,840
+30,075
| +6% | +$2.09M |
|
1005
HNI Corp
HNI
$3.51B
| $43M | 0.01% |
1,021,597
+16,821
| +2% | +$674K |
|
1006
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $42.9M | 0.01% |
758,055
-16,940
| -2% | -$943K |
|
1007
Jefferies Financial Group
JEF
$13B
| $42.9M | 0.01% |
1,155,944
-165,500
| -13% | -$6.37M |
|
1008
AGNC Investment
AGNC
$12.6B
| $42.8M | 0.01% |
2,848,920
+107,565
| +4% | +$1.7M |
|
|
EQC
1009
DELISTED
Equity Commonwealth
EQC
| $42.8M | 0.01% |
1,652,906
+25,684
| +2% | +$669K |
|
1010
AptarGroup
ATR
$8.69B
| $42.8M | 0.01% |
349,415
+9,545
| +3% | +$1.19M |
|
|
HI
1011
DELISTED
Hillenbrand
HI
| $42.8M | 0.01% |
822,934
-46,765
| -5% | -$2.23M |
|
1012
United Bankshares
UBSI
$6.72B
| $42.7M | 0.01% |
1,177,136
+72,983
| +7% | +$2.69M |
|
|
VG
1013
DELISTED
Vonage Holdings Corporation
VG
| $42.6M | 0.01% |
2,050,351
-27,667
| -1% | -$504K |
|
1014
Credit Acceptance
CACC
$6.15B
| $42.6M | 0.01% |
61,985
-4,241
| -6% | -$2.73M |
|
1015
Integra LifeSciences
IART
$1.38B
| $42.6M | 0.01% |
635,177
+18,554
| +3% | +$1.26M |
|
1016
Jazz Pharmaceuticals
JAZZ
$17B
| $42.6M | 0.01% |
333,993
+15,435
| +5% | +$2.03M |
|
1017
ScottsMiracle-Gro
SMG
$3.85B
| $42.5M | 0.01% |
264,270
+9,576
| +4% | +$1.48M |
|
1018
Acuity Brands
AYI
$10.7B
| $42.5M | 0.01% |
200,943
-550
| -0.3% | -$114K |
|
1019
Q2 Holdings
QTWO
$3.97B
| $42.2M | 0.01% |
531,462
+13,660
| +3% | +$1.1M |
|
1020
Sarepta Therapeutics
SRPT
$1.68B
| $42.2M | 0.01% |
468,279
+49,620
| +12% | +$4.24M |
|
1021
H.B. Fuller
FUL
$3.2B
| $42.1M | 0.01% |
520,334
+11,776
| +2% | +$870K |
|
1022
Euronet Worldwide
EEFT
$2.78B
| $42.1M | 0.01% |
353,602
+20,993
| +6% | +$2.49M |
|
1023
XPO
XPO
$23.4B
| $42.1M | 0.01% |
915,648
+24,646
| +3% | +$1.15M |
|
1024
MaxLinear
MXL
$6.12B
| $42M | 0.01% |
557,038
+8,134
| +1% | +$521K |
|
1025
Murphy USA
MUSA
$10.7B
| $41.8M | 0.01% |
209,952
+3,481
| +2% | +$622K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,571 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.